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Purpose: Paper-based nutrition screening tools can be challenging to implement in the ambulatory oncology 
setting. The aim of this study was to determine the validity of the Malnutrition Screening Tool (MST) and a 
novel, automated nutrition screening system compared to a ‘gold standard’ full nutrition assessment using the 
Patient-Generated Subjective Global Assessment (PG-SGA). 
Methods: An observational, cross-sectional study was conducted in an outpatient oncology day treatment unit 
(ODTU) within an Australian tertiary health service. Eligibility criteria: ≥18 years, receiving outpatient 
anticancer treatment and English literate. Patients self-administered the Malnutrition Screening Tool (MST). A 
dietitian assessed nutritional status using the PG-SGA, blinded to the MST score. Automated screening system 
data were extracted from an electronic oncology prescribing system. This system used weight loss over three to 
six weeks prior to the most recent weight record or age-categorised Body Mass Index (BMI) to identify 
nutritional risk. Sensitivity and specificity against PG-SGA (malnutrition) were calculated using contingency 
tables and Receiver Operating Curves.  
Results: N=300 oncology outpatients (51.7% male, 58.6 ± 13.3 years). The area under the curve (AUC) for 
weight loss alone was 0.69 with a cut-off value of ≥1% weight loss yielding 63% sensitivity and 76.7% 
specificity. MST (score ≥2) resulted in 70.6% sensitivity and 69.5% specificity, AUC 0.77. 
Conclusions: Both the MST and the automated method fell short of the accepted professional standard for 
sensitivity (~≥80%) derived from the PG-SGA. Further investigation into other automated nutrition screening 
options and the most appropriate parameters available electronically is warranted to support targeted service 
provision.   
Keywords: Nutrition screening, Sensitivity, Specificity, Malnutrition, Cancer, Automated  
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Introduction 
It is widely acknowledged that malnutrition is under-diagnosed and under-treated in patients with cancer. 
Nutritional status influences morbidity, response to or tolerance of treatment, quality of life, hospital admission 
rates, and health care costs [1-3]. The prevalence of cancer-related malnutrition has been reported to be as high 
as 80% [4-13]; figures likely influenced by divergent definitions of malnutrition, tumour type and stage, as well 
as treatment regimen [14].  
 
Evidence-based guidelines for the management of malnutrition [15] in relation to patients with cancer [16, 17] 
recommend routine nutrition screening to identify ‘at risk’ patients using a tool validated in the oncology 
setting. Nutrition screening is used to quickly and easily identify high risk patients for subsequent referral to an 
appropriately trained clinician (usually a dietitian) for a comprehensive nutrition assessment and management 
plan [18]. Nutrition assessment involves a more detailed investigation considering medical and nutritional 
history, as well as objective anthropometric parameters to determine an individuals’ nutritional status [13]. In 
oncology, the Scored Patient-Generated Subjective Global Assessment (PG-SGA) is commonly used for 
nutrition assessment. The PG-SGA was developed for use with cancer patients and has been validated within 
ambulatory oncology settings [13, 12, 19]. However, given the cost (time and manpower) of nutritional 
assessment, it is not practical for all oncology outpatients to undergo nutritional assessment, hence the need for 
nutritional screening. 
Traditional manual nutrition screening tools are currently favoured as a feasible method of rapidly identifying 
individuals at risk of malnutrition. However, despite being relatively less labour intensive than nutritional 
assessment, manual nutrition screening still requires staff time to undertake, to record results and to 
communicate referral to a dietitian. The Malnutrition Screening Tool (MST), has demonstrated good validity 
and reliability in identifying patients at risk of malnutrition in the oncology setting [8], and is commonly used to 
routinely screen for nutritional risk in patients with cancer in Australia. However, with growing patient numbers 
and limited staff resources, nutrition screening is often not prioritised in the outpatient setting, resulting in 
referrals being delayed or only made for those with visible physical signs of malnutrition [20]. In a recent audit 
of the Oncology Day Treatment Unit (ODTU) within this facility, 26% of patients undergoing outpatient 
anticancer treatment were malnourished; alarmingly, 22% had received no prior dietetic contact [21]. With the 
prospect of additional staffing to perform nutrition screening in this setting unlikely, despite a clear need for it, 
embedding screening within existing technology platforms was a viable alternative to explore. To our 
knowledge, there have been no studies in the oncology setting that have investigated an automated nutrition 
screening system.  
 
This study aimed to develop a novel, automated nutrition screening system and validate it against a full nutrition 
assessment using the Patient Generated-Subjective Global Assessment (PG-SGA) tool. A secondary aim was to 
compare the sensitivity and specificity of the automated screening system with that of the patient-administered 
MST.  
 
Materials and methods 
Study Design  
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This was a single site, cross sectional, observational study. All participants provided informed consent before 
participation. The protocol received approval by the Metro South Human Research Ethics Committee. 
 
Subjects  
A convenience sample of eligible, consecutive patients was offered study entry. Eligibility criteria included aged 




Data were collected over a six-week period, Monday-Friday, during April-May 2013. Patient descriptive 
information on age, gender, cancer diagnosis, chemotherapy treatment protocol, chemotherapy cycle and day, 
previous treatments, concurrent treatment and year of diagnosis were collected from the participant’s medical 
records. Data pertaining to prior cancer-related dietetic contact (i.e., location, date, current status in the dietetic 
system) were obtained from medical records and clarified with the patient or the treating dietitian. Cancer 




The MST is a nutrition screening tool [22], found to have acceptable inter-rater reliability (kappa=0.03; P 
<0.001) when administered by dietitians, medical staff, nurses, administration staff and by patients themselves 
[8]. It comprises two questions relating to recent unintentional weight loss and poor eating as a consequence of 
decreased appetite. The tool provides a score between zero to five, with patients classed as ‘at risk’ of 
malnutrition if the score is equal to or greater than two [22]. Patients in this study self-administered a written 
MST and placed it into an envelope for collection by researchers. The data collectors were blinded to the 
patients’ MST prior to undertaking their separate PG-SGA assessment.  
 
PG-SGA 
The PG-SGA consists of a medical and dietary history (weight loss, dietary intake, nutrition impact symptoms, 
functional capacity, metabolic stresses) and a physical assessment (subcutaneous fat, muscle atrophy and 
oedema). Height, weight, and weight history data were obtained from patients’ medical records, where possible. 
As in clinical practice, if these were unavailable, self-reported data were used. The PG-SGA produces the 
following global ratings; well nourished (SGA A), moderately malnourished (SGA B) or severely malnourished 
(SGA C) [20, 23]. The tool gives a total score (0-50), typically ranging from zero to thirty five [24]. In the 
oncology setting, patients will score a minimum of one, with one point allocated on the basis of proven 
malignancy. Scores greater than nine indicate a critical need for nutrition-related symptom management [20]. 
The PG-SGA was undertaken on each participant once during a scheduled chemotherapy treatment. PG-SGA 
assessments were undertaken by two dietitians. Inter-rater reliability was assessed by duplicate ratings of several 
patients prior to commencement of data collection. The lead investigator reviewed all PG-SGA assessments and 
if agreement in the global rating and score was not reached, a senior researcher, blinded to both the MST and 
automated screening results independently reviewed the data to determine the PG-SGA rating.   
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Automated Screening System  
All chemotherapy regimens within this facility are prescribed, manufactured, supplied, and administered by way 
of the electronic prescribing system/medical record CharmTM software (charmhealth, Pty Ltd, V4.2.4). This 
electronic system supports the multidisciplinary team by providing patient-centric cancer treatment information 
at the point of care. A report was generated from the electronic system data that included name, age, patient 
identification number, measured weight (recorded from electronic scales, to the nearest 0.1kg), measured height 
(recorded from a single wall-mounted stadiometer, to the nearest 0.01m) and Body Mass Index (BMI). The data 
from the electronic system that were used for comparison with PG-SGA consisted of weight loss data and BMI. 
BMI was calculated and categorised based on age; i.e., <65 years underweight (<18.5 kg/m2), normal range 
(18.5-24.9kg/m2), or overweight/obese (≥25 kg/m2) [25]; ≥65 years underweight (<22 kg/m2), normal range (22-
29.9kg/m2), or overweight/obese (≥30kg/m2) [26]. Weight was measured at periodic medical review 
appointments prior to chemotherapy administration. Weight loss was calculated over a three to six week period 
prior to the most recent weight record in the electronic system. In the case of multiple weight records within this 
timeframe, the record closest to thirty days was used. BMI was used only if a weight change record was 




Data were entered into STATA version 13.0 [27]. Receiver operating characteristic (ROC) curves and 
contingency tables were generated to determine the sensitivity (percentage of malnourished correctly identified 
as such in comparison to the PG-SGA) and specificity (percentage of well-nourished correctly identified as such 
compared to the PG-SGA). Positive predictive values (PPV) and negative predictive values (NPV) (i.e., the 
likelihood that the tool accurately predicts the presence or absence respectively of malnutrition) of the 
automated screening system compared to the PG-SGA were also calculated. This was similarly done for the 
MST. For the purpose of statistical analyses, nutritional status was classified as two groups; ‘well-nourished’ 
(SGA A) and ‘malnourished’ with SGA B and SGA C merging.  
 
Results 
General characteristics of study participants  
Table 1 outlines the general characteristics of study participants. 312 eligible patients were identified with 300 
consenting (96.2% participation). Reasons for non-participation included chemotherapy-associated fatigue and 
minimal remaining time of the chemotherapy infusion. The mean participant age was 58.6 ± 13.4 years and 
51.7% were male (n=155). The most common cancer diagnoses were haematological (31.3%), followed by 
gastrointestinal (21%) and breast cancers (19.7%).  
 
Nutritional status and BMI 
Using the PG-SGA global rating, 83% (n=249) of participants were well-nourished (PG-SGA A) and 17% 
(n=51) were malnourished (SGA B n=46; SGA C n=5) (Table 1). Malnourished patients had significantly lower 
body weight and BMI than well-nourished patients (P= <0.001). Malnutrition varied between diagnoses (P= 
0.039), with 37.5% of head and neck patients being malnourished, followed by 27% of those with 
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gastrointestinal malignancies, 14.9% with haematological diagnoses, 12% with lung and 10.2% with breast 
malignancies. More than half the participants (53%, n=159) were overweight or obese for their age, whilst 7% 
(n=21) were underweight.   
 
Performance of the automated nutrition screening system and MST compared to PG-SGA 
Table 2 outlines the results. According to the MST, 37.2% (n=112) of patients were at risk of malnutrition 
(score ≥2). The MST had a 70.6% sensitivity and 69.7% specificity compared to the PG-SGA. For the 
automated system, weight change data were available for 245 patients, age-categorised BMI was available for 
40 patients without weight change data, and 15 patients had no weight and height data recorded. Different cut-
offs were used for these variables within the automated tool to determine the best sensitivity, specificity, 
predictive values and accuracy compared to the PG-SGA. Using cut-offs of weight loss of ≥1% in three to six 
weeks or age-categorised underweight BMI, these variables provided 30.6% sensitivity and 71.6% specificity 
compared to the PG-SGA. When BMI was removed (n=245), the sensitivity of weight loss of ≥ 1% was 63.0% 
and specificity was 76.7%.  
 
Discussion 
The best performing automated screening criteria using a combination of weight loss and underweight BMI 
(≥1% weight loss in three to six weeks or age-categorised underweight BMI) showed reasonable specificity but 
low sensitivity against the full nutritional assessment by the PG-SGA. Once underweight, age-categorised BMI 
was removed, the sensitivity and specificity using the ≥1% cut off value improved, however still failed to reach 
the accepted professional standard of 80%. We therefore cannot recommend any of the automated screening 
system methods in their current format. Further research into the most appropriate electronic parameters is 
warranted. It is worth exploring a wider time period for weight changes, as the one utilised in this study may 
have been too short. Furthermore, given that underweight age-categorised BMI alone performed poorly in 
sensitivity, this particular automated system may only have potential in monitoring patients who are at risk of 
malnutrition once they are well established on treatment.  
 
The literature supports nutritional screening within the oncology population. However, studies to date have 
focused on manual, paper-based screening methods. This is the first study to investigate the effectiveness of an 
automated nutrition screening system to assess nutritional risk in the ambulatory oncology outpatient 
population. Research however has progressed in other clinical areas. In the surgical setting, Smith et al. [28] 
used Brugler’s simplified screening tool for malnutrition-related complications (MRCS) to rank six variables 
(three biochemical parameters, wound presence, presence of high risk illness, and poor nutritional intake) to 
enable automated screening in hospitalised patients. The MRCS proved to be the more predictive of 
postoperative complications compared to the SGA. The MRCS however has not been investigated outside the 
acute surgical setting and might not be transferable to the ambulatory oncology setting.  
 
Although the MST performed better than the automated system in this study, it also fell short of the accepted 
professional standard for sensitivity (~80%) against the PG-SGA. Other studies of oncology populations have 
reported more acceptable sensitivity and specificity when comparing the MST to the PG-SGA. For example, 
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Isenring et al. [8] reported 100% sensitivity and 92% specificity in 50 oncology outpatients with mixed 
diagnoses, while Ferguson et al. [29] reported 100% sensitivity and 81% specificity in 106 oncology outpatients 
undergoing radiotherapy. Gabrielson et al. [4] reported 81.3% sensitivity and 72.4% specificity in 90 
chemotherapy outpatients with mixed diagnoses. The lower sensitivity in our study could be related to the MST 
being self-completed. Despite this tool being relatively quick and easy, its administration by clinicians in this 
particular outpatient setting has not been possible due to limited human and financial resources.  
 
According to the PG-SGA global rating, the prevalence of malnutrition in this study was 17%. Other studies of 
smaller samples using the SGA or PG-SGA identified malnutrition prevalence in oncology outpatients receiving 
chemotherapy around 25% [8, 21]. A larger variation in malnutrition prevalence was found using the SGA or 
PG-SGA in oncology outpatients undergoing radiotherapy, with findings between 11-35% [24, 29]. Despite the 
reduction in malnutrition at this site compared to a previous audit [21], 41.2% of malnourished patients in the 
present study (n=21) were not known to the dietetic system, confirming the need for formalised nutrition 
screening in this setting.  
 
The strengths of this study are that nutritional assessments were conducted by dietitians blinded to nutritional 
screening results, the relatively large sample size, the representative sample of patients recruited, and the 
excellent participant response rate. Limitations include no weight and height data being available for 5% (n=15) 
of patients undergoing anti-cancer treatment in the study.  
 
Conclusion  
With the direction of medical records trending towards electronic systems, the investigation of automated or 
computerised nutrition screening systems is timely. Nonetheless, challenges do exist. Electronic medical record 
systems can provide benefits in terms of efficiency, safety and timely access to information; however, there are 
notable risks if they are not properly implemented, maintained or used. Whilst the present study did not 
demonstrate acute weight change within a three to six week period to be a valid screening method, it will inform 
future research into novel automated screening tools to manage the vast numbers of cancer patients receiving 
chemotherapy to support targeted dietetic service provision. Suggestions for future studies are to explore the 
most clinically-relevant electronic nutritional parameters. 
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 Table 1 Clinical variables for cancer patients as classified by SGA global rating 
Variable All patients Well nourished 





Patients [N, (%)] 300 (100) 249 (83) 51 (17)  
Sex [n, (%)]     
   Male 155 (51.7) 123 (79.4) 32 (20.6) 0.113+ 
   Female 145 (48.3) 126 (86.9) 19 (13.1)  
Age (y) 58.6 ± 13.4 58.9 ± 13.1  56.6 ± 13.8 0.253# 
Type of cancera [n, (%)]     
   Breast 59 (19.7) 53 (89.8) 6 (10.2) 0.039+ 
   Gastrointestinal 63 (21) 46 (73) 17 (27)  
   Haematological 94 (31.3) 80 (85.1) 14 (14.9)  
   Head and neck 16 (5.3) 10 (62.5) 6 (37.5)  
   Lung 50 (16.7) 44 (88) 6 (12)  
   Other 18 (6) 16 (88.9) 2 (11.1)  
Weight (kg) 79.3 ± 20.4 82.3 ± 20.5 64.9 ± 12.1 <0.001# 
BMI (kg/m2) 27.8 ± 6.8 28.9 ± 6.7 22.6 ± 4.5 <0.001# 
aCancer diagnosis: ‘Gastrointestinal’ cancer included colorectal (n=35), oesophageal (n=10), pancreatic (n=8), gastric (n=3), gall bladder 
(n=2), cholangiocarcinoma (n=2), duodenal (n=2), and appendiceal (n=1) cancers. ‘Haematological’ diagnoses included lymphoma (n=52), 
multiple myeloma (n=23), leukaemia (n=18), myelodysplastic syndrome (n=1). ‘Other’ cancers included: sarcoma (n=6), prostate cancer 
(n=4), carcinoma of unknown primary (n=2), renal cell carcinoma (n=2), germ cell tumour (n=2), medullablastoma (n=1), and seminoma 
(n=1).   
+Comparing well nourished to malnourished patients using chi-squared test 
#Comparing well nourished to malnourished patients using independent sample t test 
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Table 2 Area under Receiver Operating Characteristic Curves, sensitivity, specificity, predictive values and  
accuracy in predicting malnutrition assessed by the PG-SGA rating (SGA B/C) (N=300) 
 
^ <65 years of age, BMI <18.5kg/m2; ≥65 years of age, BMI <22kg/m2 
#BMI was only used if weight loss data was unavailable  
PG-SGA = Patient-Generated Subjective Global Assessment; CI = Confidence Interval; BMI = Body Mass 
Index, MST = Malnutrition Screening Tool. 
 
 






















≥1% weight loss in 3-6 
weeks or underweight 
BMI^# 
 
30.6 71.6 18.3 83.3   
Underweight BMI^  
 
18.4 94.9 42.9 84.8   
≥1% weight loss in 3-6 
weeks 
 
63.0 76.7   0.69  
(0.61-0.76) 
74.4 
MST ≥2  70.6 69.5   0.77  
(0.72-0.82) 
69.7 
